Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Fluidigm Corporation

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted equity awards effective as of... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate in Upcoming Health Care Investor Conferences
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces First Quarter 2019 Financial Results
Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the first quarter ended March 31, 2019. 
Tickers FLDM
From GlobeNewswire News Releases
Leading Cancer Center in Japan Selects Hyperion Imaging System to Expand Immuno-Oncology Research Studies in Colorectal Cancer
Fluidigm Corporation (NASDAQ:FLDM) announced today that the Group for Innovative Cancer Treatment Division of the National Cancer Center in Japan has expanded its clinical research in colorectal cancer... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces 8th Annual Mass Cytometry Summit
Fluidigm invites researchers to the world’s largest global mass cytometry conference in Vancouver, Canada 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Conference Call and Webcast of First Quarter 2019 Financial Results
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that it will report first quarter 2019... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting
A comprehensive suite of multi-omic cancer research solutions for deep profiling of the tumor microenvironment and immune response 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry
The new standard in immune profiling for advancing translational and clinical research of immune-mediated diseases 
Tickers FLDM
From GlobeNewswire News Releases
Colin McCracken Joins Fluidigm as Chief Commercial Officer
Fluidigm Corporation (NASDAQ:FLDM) today announced that Colin McCracken has joined the company as its Chief Commercial Officer. 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate in Upcoming Investor Conferences
Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that the company’s management will... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, granted equity awards effective as of... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Fourth Quarter and Full Year 2018 Financial Results
Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the fourth quarter and full year ended December 31, 2018. 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations
Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis for Imaging Mass Cytometry™ (IMC™). Under the... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases
Fluidigm Corporation (NASDAQ: FLDM) today announced it is one of 11 partners in the TIMID Consortium, a unique effort of six academic institutions and five life science and pharma companies that... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Introduces REAP-Seq for Multi-Omic Single-Cell Analysis on the C1
First commercially available, automated single-cell analysis application to enable co-detection of cellular protein and RNA expression using microfluidics technology 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2018 Financial Results
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report fourth quarter and full year 2018 financial results on Thursday,... 
Tickers FLDM
From GlobeNewswire News Releases
Caprion Biosciences Offers Mass Cytometry CRO Services to Advance Biomarker Discovery and Immune Monitoring
Mass cytometry services for pharmaceutical and biotechnology companies to accelerate development of new health insights 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its previously announced underwritten public offering of 9,372,500 shares... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock
Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an underwritten public offering of 8,150,000 shares of its common stock at... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Commencement of Public Offering of Common Stock
Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to offer and sell, subject to market and other conditions, shares of its... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference
Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s management team will participate in the 30th Annual Piper Jaffray... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised entirely of independent directors, granted equity awards effective as of... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technology, is showcasing its latest innovations for immuno-oncology research during the 33rd Annual Meeting of the... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Recognized as a Company to Watch in 2019
BioInformatics Inc., the leading research and advisory firm serving the life science tool market, today announced Fluidigm as the Company to Watch in 2019 at the biannual Life Science Industry Awards®... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Third Quarter 2018 Financial Results
Fluidigm Corporation (NASDAQ:FLDM) today announced financial results for the third quarter ended September 30, 2018. 
Tickers FLDM
From GlobeNewswire News Releases
Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development
Sirona Dx, a leader in high-complexity genomics and proteomics services, today announced the introduction of Imaging Mass Cytometry™ services on the Fluidigm Hyperion™ Imaging System to advance... 
Tickers FLDM
From GlobeNewswire News Releases
Laura Clague Named to Fluidigm Board of Directors
Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to the company’s Board of Directors and its audit committee. Clague is Chief Financial Officer of Retrophin, Inc.,... 
Tickers FLDM
From GlobeNewswire News Releases
Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technology, today announced the publication of the 10,000 Immunomes Project (10KIP), a seminal human immune reference... 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD
Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research 
Tickers FLDM
From GlobeNewswire News Releases
Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report third quarter financial results on Thursday, November 1, 2018, after... 
Tickers FLDM
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.